Poland· PL-100489812
Tentin
A dexamfetamine product containing dexamfetamini sulfas, registered in Poland by Medice Arzneimittel Puetter GmbH & Co. KG. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dexamfetamine is registered in 14 of 19 countries.
Countries holding a registration under ATC N06BA02 (dexamfetamine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Dexamfetamine · ATC N06BA02
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamfetamine costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamfetamine · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.49
The record
At a glance
URPL (Poland)- Active substance
- Dexamfetamini sulfas
- Manufacturer
- Medice Arzneimittel Puetter GmbH & Co. KG
- Country
- Poland (PL)
- ATC code
- N06BA02
- ATC class
- Dexamfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991554866
- gtin05909991554880
- gtin05909991554873
- gtin05909991554910
- gtin05909991554897
- gtin05909991554903
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for dexamfetamine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamfetamine · interactions on record
89 records
- 16 severe
- 73 moderate
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- ProcarbazineL01XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexamfetamine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDextroamphetamine SulfateWilshire Pharmaceuticals, Inc.
- United KingdomAmfexa 5mg tabletsMedice UK Ltd
- NetherlandsAdhesa 5 mg tablettenACE Pharmaceuticals B.V.
- SwedenAdhesa 5 mg TablettAdvanz Pharma Limited
- FinlandAdhesaACE Pharmaceuticals BV
- NorwayAttentinMedice Arzneimittel Pütter GmbH & Co KG
- CanadaDEXEDRINEENDO OPERATIONS LTD.
- IcelandAttentinMedice Arzneimittel Pütter GmbH & Co. KG*
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Philla
- Belgium · Adhesa, Attentin
- Germany · Attentin, Dexamfetamin Orifarm
- Denmark · Adhesa, Attentin
- Estonia · Tentin
- Spain · Tentin
- Finland · Adhesa 5 Mg Tabletti, Attadex
- France · Tentin
- United Kingdom (Northern Ireland) · Amfexa, Dexamfetamine Sulfate
- Iceland · Attentin, Dexamfetamine Taw Pharma (Ireland)
- Italy · Amfexa
- Luxembourg · Attentin
- Malta · Dexamfetamine Sulfate
- Netherlands · Adhesa, Attenfarm
- Norway · Attentin, Deksamfetamin Waymade B.V.
- Portugal · Tentin
- Sweden · Attentin, Dexamfetamin Sea Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03eee4ce-a5df-4748-9b2d-b2085b60bb36 GET /v1/drugs/03eee4ce-a5df-4748-9b2d-b2085b60bb36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909991554866 ¦ Rpw ¦ 157160\n20 tabl.\n05909991554880 ¦ Rpw ¦ 157161\n30 tabl.\n05909991554873 ¦ Rpw ¦ 157162\n28 tabl.\n05909991554910 ¦ Rpw ¦ 157163\n100 tabl.\n05909991554897 ¦ Rpw ¦ 157164\n50 tabl.\n05909991554903 ¦ Rpw ¦ 157165\n98 tabl.",
"substance": "Dexamfetamini sulfas 5 mg",
"common_name": "Dexamfetamini sulfas",
"pl_product_id": "100489812",
"pozwolenie_nr": "28608",
"auth_procedure": "MRP",
"authorisation_validity": "2029-09-23"
}See everything about dexamfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.